Search Results - "Zhang, Saijuan"
-
1
Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial
Published in Nature medicine (01-10-2021)“…Islatravir (MK-8591) is a highly potent type 1 human immunodeficiency virus (HIV-1) nucleoside reverse transcriptase translocation inhibitor with a long…”
Get full text
Journal Article -
2
Safety and Pharmacokinetics of Once-Daily Multiple-Dose Administration of Islatravir in Adults Without HIV
Published in Journal of acquired immune deficiency syndromes (1999) (01-11-2021)“…Islatravir (MK-8591) is a novel nucleoside analog in development for the treatment and prevention of HIV-1 infection. Islatravir has potent antiviral activity…”
Get full text
Journal Article -
3
Single Oral Doses of MK-8507, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor, Suppress HIV-1 RNA for a Week
Published in Journal of acquired immune deficiency syndromes (1999) (01-02-2022)“…MK-8507 is a novel HIV-1 non-nucleoside reverse transcriptase inhibitor being developed for treatment of HIV-1 infection. MK-8507 has high antiviral potency in…”
Get full text
Journal Article -
4
Fitting a bivariate measurement error model for episodically consumed dietary components
Published in The international journal of biostatistics (06-01-2011)“…There has been great public health interest in estimating usual, i.e., long-term average, intake of episodically consumed dietary components that are not…”
Get more information
Journal Article -
5
A Phase 1 Trial to Evaluate the Relationship Between Fluoride Intake and Urinary Fluoride Excretion in Healthy Participants
Published in Journal of clinical pharmacology (01-02-2022)“…Chronic overexposure to fluoride can have deleterious effects in the musculoskeletal system. Some fluorine‐containing therapeutics, such as voriconazole,…”
Get full text
Journal Article -
6
Fluoride Pharmacokinetics in Urine and Plasma Following Multiple Doses of MK‐8507, an Investigational, Oral, Once‐Weekly Nonnucleoside Reverse Transcriptase Inhibitor
Published in Journal of clinical pharmacology (01-02-2022)“…MK‐8507 is an investigational HIV‐1 nonnucleoside reverse transcriptase inhibitor being developed for the treatment of HIV‐1 infection. MK‐8507 contains 2…”
Get full text
Journal Article -
7
-
8
Safety, pharmacokinetics, and antiretroviral activity of islatravir (ISL, MK-8591), a novel nucleoside reverse transcriptase translocation inhibitor, following single-dose administration to treatment-naive adults infected with HIV-1: an open-label, phase 1b, consecutive-panel trial
Published in The lancet HIV (01-03-2020)“…Islatravir (also known as ISL and MK-8591) is a unique nucleoside reverse transcriptase translocation inhibitor in clinical development for treatment of people…”
Get full text
Journal Article -
9
A Phase 1 Study to Evaluate the Drug Interaction Between Islatravir (MK-8591) and Doravirine in Adults Without HIV
Published in Clinical drug investigation (01-07-2021)“…Background and Objectives Islatravir (MK-8591) is a novel nucleoside analogue in development for the treatment and prevention of HIV-1 infection. Doravirine is…”
Get full text
Journal Article -
10
A phase 1, open‐label study to evaluate the drug interaction between islatravir (MK‐8591) and the oral contraceptive levonorgestrel/ethinyl estradiol in healthy adult females
Published in Journal of the International AIDS Society (01-12-2021)“…Introduction Hormonal contraceptives are among the most effective forms of reversible contraception, but many other compounds, including some antiretrovirals,…”
Get full text
Journal Article -
11
Lack of a Clinically Meaningful Drug Interaction Between the HIV‐1 Antiretroviral Agents Islatravir, Dolutegravir, and Tenofovir Disoproxil Fumarate
Published in Clinical pharmacology in drug development (01-12-2021)“…Islatravir, an investigational nucleoside reverse transcriptase translocation inhibitor, is in clinical development for the treatment and prevention of HIV‐1…”
Get full text
Journal Article -
12
A NEW MULTIVARIATE MEASUREMENT ERROR MODEL WITH ZERO-INFLATED DIETARY DATA, AND ITS APPLICATION TO DIETARY ASSESSMENT
Published in The annals of applied statistics (01-06-2011)“…In the United States the preferred method of obtaining dietary intake data is the 24-hour dietary recall, yet the measure of most interest is usual or longterm…”
Get full text
Journal Article -
13
Optimized human factor IX expression cassettes for hepaticdirected gene therapy of hemophilia B
Published in 医学前沿:英文版 (2015)“…Gene therapy provides a potential cure for hemophilia B, and significant progress has been achieved in liver-directed gene transfer mediated by…”
Get full text
Journal Article -
14
Intake_epis_food(): An R Function for Fitting a Bivariate Nonlinear Measurement Error Model to Estimate Usual and Energy Intake for Episodically Consumed Foods
Published in Journal of statistical software (05-03-2012)“…We consider a Bayesian analysis using WinBUGS to estimate the distribution of usual intake for episodically consumed foods and energy (calories). The model…”
Get full text
Journal Article -
15
Predicting surgical case durations using ill-conditioned CPT code matrix
Published in IIE transactions (01-02-2010)“…Efficient utilization of existing resources is crucial for cost containment in medical institutions. Accurately predicting surgery duration will improve the…”
Get full text
Journal Article -
16
A new multivariate measurement error model with zero-inflated dietary data, and its application to dietary assessment
Published 25-07-2011“…Annals of Applied Statistics 2011, Vol. 5, No. 2B, 1456-1487 In the United States the preferred method of obtaining dietary intake data is the 24-hour dietary…”
Get full text
Journal Article